A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine
Creative Commons Attribution (CC-BY)
science
2022-05-28 00:00:00

Open AccessArticle by
 1,*, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2,* and 1,* 


1
Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China


2
Department of Biology, College of Life Sciences, China Jiliang University, Hangzhou 310018, China


*
Authors to whom correspondence should be addressed. 



Academic Editor: Elmostafa Bahraoui

Viruses 2022, 14(6), 1174; https://doi.org/10.3390/v14061174 (registering DOI)


Received: 7 April 2022
/
Revised: 15 May 2022
/
Accepted: 27 May 2022
/
Published: 28 May 2022
 

Influenza virus infects the host and transmits through the respiratory tract (i.
